{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2024,2,10]],"date-time":"2024-02-10T00:25:49Z","timestamp":1707524749301},"reference-count":30,"publisher":"Springer Science and Business Media LLC","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2022,9,21]]},"DOI":"10.7759\/cureus.29399","type":"journal-article","created":{"date-parts":[[2022,9,21]],"date-time":"2022-09-21T12:04:48Z","timestamp":1663761888000},"source":"Crossref","is-referenced-by-count":0,"title":["Examples of Outcome Reporting Bias in Vaccine Studies: Illustrating How Perpetuating Medical Consensus Can Impede Progress in Public Health"],"prefix":"10.7759","author":[{"given":"Gary S","family":"Goldman","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","reference":[{"key":"ref1","doi-asserted-by":"publisher","DOI":"10.1186\/1746-6215-11-37","article-title":"Reporting bias in medical research - a narrative review","volume":"11","author":"McGauran N","year":"2010","unstructured":"McGauran N, Wieseler B, Kreis J, Sch\u00fcler YB, K\u00f6lsch H, Kaiser T. Reporting bias in medical research - a narrative review. Trials. 2010, 11:37-10. 10.1186\/1746-6215-11-37","journal-title":"Trials"},{"key":"ref2","doi-asserted-by":"publisher","DOI":"10.1038\/news.2010.564","article-title":"Questions raised over medical journal financial ties to industry","author":"Callay E","year":"2022","unstructured":"Callay E. Questions raised over medical journal financial ties to industry. Nature. 2022, 10.1038\/news.2010.564","journal-title":"Nature"},{"key":"ref3","article-title":"The truth about drug companies: how they deceive us and what to do about it","author":"Angell M","year":"2005","unstructured":"Angell M. The truth about drug companies: how they deceive us and what to do about it. Random House, New York; 2005."},{"key":"ref4","unstructured":"Offline. what is medicine\u2019s 5 sigma?. (2022). Accessed: July 23, 2022: https:\/\/www.thelancet.com\/pdfs\/journals\/lancet\/PIIS0140-6736%2815%2960696-1.pdf."},{"key":"ref5","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(21)02046-8","article-title":"Considerations in boosting COVID-19 vaccine immune responses","volume":"398","author":"Krause PR","year":"2021","unstructured":"Krause PR, Fleming TR, Peto R, et al.. Considerations in boosting COVID-19 vaccine immune responses. Lancet. 2021, 398:1377-80. 10.1016\/S0140-6736(21)02046-8","journal-title":"Lancet"},{"key":"ref6","doi-asserted-by":"crossref","DOI":"10.1037\/1089-2680.2.2.175","article-title":"Confirmation bias in ubiquitous phenomenon in many guises","volume":"2","author":"Nickerson RS","year":"1998","unstructured":"Nickerson RS. Confirmation bias in ubiquitous phenomenon in many guises. Rev Gen Psychol. 1998, 2:175-220.","journal-title":"Rev Gen Psychol"},{"key":"ref7","doi-asserted-by":"publisher","DOI":"10.1177\/088307380401900606","article-title":"Mercury exposure in children with autistic spectrum disorder: case-control study","volume":"19","author":"Ip P","year":"2004","unstructured":"Ip P, Wong V, Ho M, Lee J, Wong W. Mercury exposure in children with autistic spectrum disorder: case-control study. J Child Neurol. 2004, 19:431-4. 10.1177\/088307380401900606","journal-title":"J Child Neurol"},{"key":"ref8","doi-asserted-by":"publisher","DOI":"10.1177\/0883073807307111","article-title":"Blood levels of mercury are related to diagnosis of autism: a reanalysis of an important data set","volume":"22","author":"Desoto MC","year":"2007","unstructured":"Desoto MC, Hitlan RT. Blood levels of mercury are related to diagnosis of autism: a reanalysis of an important data set. J Child Neurol. 2007, 22:1308-11. 10.1177\/0883073807307111","journal-title":"J Child Neurol"},{"key":"ref9","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa021134","article-title":"A population-based study of measles, mumps, and rubella vaccination and autism","volume":"347","author":"Madsen KM","year":"2002","unstructured":"Madsen KM, Hviid A, Vestergaard M, et al.. A population-based study of measles, mumps, and rubella vaccination and autism. N Engl J Med. 2002, 347:1477-82. 10.1056\/NEJMoa021134","journal-title":"N Engl J Med"},{"key":"ref10","doi-asserted-by":"publisher","DOI":"10.1542\/peds.112.3.604","article-title":"Thimerosal and the occurrence of autism: negative ecological evidence from Danish population-based data","volume":"112","author":"Madsen KM","year":"2003","unstructured":"Madsen KM, Lauritsen MB, Pedersen CB, Thorsen P, Plesner AM, Andersen PH, Mortensen PB. Thimerosal and the occurrence of autism: negative ecological evidence from Danish population-based data. Pediatrics. 2003, 112:604-6. 10.1542\/peds.112.3.604","journal-title":"Pediatrics"},{"key":"ref11","unstructured":"Infant vaccination does not predict increased infant mortality rate. correcting past information. (2021). Accessed: July 23, 2022: https:\/\/www.medrxiv.org\/content\/10.1101\/2021.09.03.21263082v1."},{"key":"ref12","doi-asserted-by":"publisher","DOI":"10.1177\/0960327111407644","article-title":"Infant mortality rates regressed against number of vaccine doses routinely given: is there a biochemical or synergistic toxicity?","volume":"30","author":"Miller NZ","year":"2011","unstructured":"Miller NZ, Goldman GS. Infant mortality rates regressed against number of vaccine doses routinely given: is there a biochemical or synergistic toxicity?. Hum Exp Toxicol. 2011, 30:1420-8. 10.1177\/0960327111407644","journal-title":"Hum Exp Toxicol"},{"key":"ref13","doi-asserted-by":"publisher","DOI":"10.20944\/preprints202206.0240.v1","article-title":"Bailey\u2019s reanalysis fails to debunk, and inadvertently supports, Miller-Goldman\u2019s positive correlation between number of vaccine doses and infant mortality rates","volume":"15","author":"Goldman GS","year":"2022","unstructured":"Goldman GS, Miller NZ. Bailey\u2019s reanalysis fails to debunk, and inadvertently supports, Miller-Goldman\u2019s positive correlation between number of vaccine doses and infant mortality rates. Preprints June. 2022, 15:10.20944\/preprints202206.0240.v1","journal-title":"Preprints June"},{"key":"ref14","doi-asserted-by":"publisher","DOI":"10.1542\/peds.2005-2993","article-title":"Pervasive developmental disorders in Montreal, Quebec, Canada: prevalence and links with immunizations","volume":"118","author":"Fombonne E","year":"2006","unstructured":"Fombonne E, Zakarian R, Bennett A, Meng L, McLean-Heywood D. Pervasive developmental disorders in Montreal, Quebec, Canada: prevalence and links with immunizations. Pediatrics. 2006, 118:e139-50. 10.1542\/peds.2005-2993","journal-title":"Pediatrics"},{"key":"ref15","doi-asserted-by":"publisher","DOI":"10.1093\/cid\/ciw296","article-title":"Increasing incidence of herpes zoster over a 60-year period from a population-based study","volume":"63","author":"Kawai K","year":"2016","unstructured":"Kawai K, Yawn BP, Wollan P, Harpaz R. Increasing incidence of herpes zoster over a 60-year period from a population-based study. Clin Infect Dis. 2016, 63:221-6. 10.1093\/cid\/ciw296","journal-title":"Clin Infect Dis"},{"key":"ref16","article-title":"The nature of herpes zoster: a long-term study and a new hypothesis","volume":"58","author":"Hope-Simpson RE","year":"1965","unstructured":"Hope-Simpson RE. The nature of herpes zoster: a long-term study and a new hypothesis. Proc R Soc Med. 1965, 58:9-20.","journal-title":"Proc R Soc Med"},{"key":"ref17","doi-asserted-by":"publisher","DOI":"10.7759\/cureus.16963","article-title":"Insights on the impact of external and internal boosting on varicella-zoster virus reactivation based on evidence from the first decade of the United States universal varicella vaccination program","volume":"13","author":"Goldman GS","year":"2021","unstructured":"Goldman GS. Insights on the impact of external and internal boosting on varicella-zoster virus reactivation based on evidence from the first decade of the United States universal varicella vaccination program. Cureus. 2021, 13:e16963. 10.7759\/cureus.16963","journal-title":"Cureus"},{"key":"ref18","doi-asserted-by":"publisher","DOI":"10.1016\/j.ajog.2010.08.050","article-title":"Adverse events in pregnant women following administration of trivalent inactivated influenza vaccine and live attenuated influenza vaccine in the Vaccine Adverse Event Reporting System, 1990-2009","volume":"204","author":"Moro PL","year":"2011","unstructured":"Moro PL, Broder K, Zheteyeva Y, et al.. Adverse events in pregnant women following administration of trivalent inactivated influenza vaccine and live attenuated influenza vaccine in the Vaccine Adverse Event Reporting System, 1990-2009. Am J Obstet Gynecol. 2011, 204:146.e1-7. 10.1016\/j.ajog.2010.08.050","journal-title":"Am J Obstet Gynecol"},{"key":"ref19","doi-asserted-by":"publisher","DOI":"10.1177\/0960327112455067","article-title":"Comparison of VAERS fetal-loss reports during three consecutive influenza seasons: was there a synergistic fetal toxicity associated with the two-vaccine 2009\/2010 season?","volume":"32","author":"Goldman GS","year":"2013","unstructured":"Goldman GS. Comparison of VAERS fetal-loss reports during three consecutive influenza seasons: was there a synergistic fetal toxicity associated with the two-vaccine 2009\/2010 season?. Hum Exp Toxicol. 2013, 32:464-75. 10.1177\/0960327112455067","journal-title":"Hum Exp Toxicol"},{"key":"ref20","doi-asserted-by":"publisher","DOI":"10.1016\/j.ajog.2011.06.047","article-title":"Adverse events following administration to pregnant women of influenza A (H1N1) 2009 monovalent vaccine reported to the Vaccine Adverse Event Reporting System","volume":"205","author":"Moro PL","year":"2011","unstructured":"Moro PL, Broder K, Zheteyeva Y, et al.. Adverse events following administration to pregnant women of influenza A (H1N1) 2009 monovalent vaccine reported to the Vaccine Adverse Event Reporting System. Am J Obstet Gynecol. 2011, 205:473.e1-9. 10.1016\/j.ajog.2011.06.047","journal-title":"Am J Obstet Gynecol"},{"key":"ref21","doi-asserted-by":"publisher","DOI":"10.1080\/02772248.2012.724574","article-title":"Maternal transfer of mercury to the developing embryo\/fetus: is there a safe level?","volume":"94","author":"Brown IA","year":"2012","unstructured":"Brown IA, Austin DW. Maternal transfer of mercury to the developing embryo\/fetus: is there a safe level?. Toxicol Environ Chem. 2012, 94:1610-1627. 10.1080\/02772248.2012.724574","journal-title":"Toxicol Environ Chem"},{"key":"ref22","doi-asserted-by":"publisher","DOI":"10.1016\/j.vaccine.2014.04.085","article-title":"Vaccines are not associated with autism: an evidence-based meta-analysis of case-control and cohort studies","volume":"32","author":"Taylor LE","year":"2014","unstructured":"Taylor LE, Swerdfeger AL, Eslick GD. Vaccines are not associated with autism: an evidence-based meta-analysis of case-control and cohort studies. Vaccine. 2014, 32:3623-9. 10.1016\/j.vaccine.2014.04.085","journal-title":"Vaccine"},{"key":"ref23","article-title":"Morbidity and mortality weekly report (MMWR). Prevention and Control of Influenza Recommendations of the Advisory Committee on Immunization Practices","volume":"53","author":"Harper SA","year":"200428","unstructured":"Harper SA, Fukuda K, Uyeki TM, Cox NJ, Bridges CB; Centers for Disease Control and Prevention (CDC). Morbidity and mortality weekly report (MMWR). Prevention and Control of Influenza Recommendations of the Advisory Committee on Immunization Practices. ACIP. 200428, 53:1-40.","journal-title":"ACIP"},{"key":"ref24","doi-asserted-by":"publisher","DOI":"10.1016\/j.phrs.2015.08.003","article-title":"Vaccines, adjuvants and autoimmunity","volume":"100","author":"Guimar\u00e3es LE","year":"2015","unstructured":"Guimar\u00e3es LE, Baker B, Perricone C, Shoenfeld Y. Vaccines, adjuvants and autoimmunity. Pharmacol Res. 2015, 100:190-209. 10.1016\/j.phrs.2015.08.003","journal-title":"Pharmacol Res"},{"key":"ref25","article-title":"Rapid Medical Countermeasure Response to Infectious Diseases: Workshop Summary","author":"The National Academies of Science","year":"2016","unstructured":"The National Academies of Science, Engineering, Medicine. Rapid Medical Countermeasure Response to Infectious Diseases: Workshop Summary. National Academies Press, Washington; 2016."},{"key":"ref26","doi-asserted-by":"publisher","DOI":"10.1177\/08830738060210021401","article-title":"Developmental regression and mitochondrial dysfunction in a child with autism","volume":"21","author":"Poling JS","year":"2006","unstructured":"Poling JS, Frye RE, Shoffner J, Zimmerman AW. Developmental regression and mitochondrial dysfunction in a child with autism. J Child Neurol. 2006, 21:170-172. 10.1177\/08830738060210021401","journal-title":"J Child Neurol"},{"key":"ref27","doi-asserted-by":"publisher","DOI":"10.1086\/596476","article-title":"Vaccines and autism: a tale of shifting hypotheses","volume":"48","author":"Gerber JS","year":"2009","unstructured":"Gerber JS, Offit PA. Vaccines and autism: a tale of shifting hypotheses. Clin Infect Dis. 2009, 48:456-61. 10.1086\/596476","journal-title":"Clin Infect Dis"},{"key":"ref28","unstructured":"CDC. Autism may be more prevalent than previous estimates. Science Daily Feb. 8. (2007). Accessed. July 23, 2022: http:\/\/www.sciencedaily.com\/releases\/2007\/02\/070208134841.htm."},{"key":"ref29","doi-asserted-by":"publisher","DOI":"10.1038\/cmi.2017.151","article-title":"Vaccine-induced autoimmunity: the role of molecular mimicry and immune crossreaction","volume":"15","author":"Segal Y","year":"2018","unstructured":"Segal Y, Shoenfeld Y. Vaccine-induced autoimmunity: the role of molecular mimicry and immune crossreaction. Cell Mol Immunol. 2018, 15:586-94. 10.1038\/cmi.2017.151","journal-title":"Cell Mol Immunol"},{"key":"ref30","doi-asserted-by":"publisher","DOI":"10.1016\/j.rasd.2019.101502","article-title":"The lifetime social cost of autism: 1990-2029","volume":"72","author":"Cakir J","year":"2020","unstructured":"Cakir J, Fryer RE, Walker SJ. The lifetime social cost of autism: 1990-2029. Res Autism Spectr Disord. 2020, 72:101502. 10.1016\/j.rasd.2019.101502","journal-title":"Res Autism Spectr Disord"}],"container-title":["Cureus"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.cureus.com\/articles\/110238-examples-of-outcome-reporting-bias-in-vaccine-studies-illustrating-how-perpetuating-medical-consensus-can-impede-progress-in-public-health","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,2,9]],"date-time":"2024-02-09T19:39:10Z","timestamp":1707507550000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.cureus.com\/articles\/110238-examples-of-outcome-reporting-bias-in-vaccine-studies-illustrating-how-perpetuating-medical-consensus-can-impede-progress-in-public-health"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,9,21]]},"references-count":30,"URL":"https:\/\/doi.org\/10.7759\/cureus.29399","relation":{},"ISSN":["2168-8184"],"issn-type":[{"value":"2168-8184","type":"print"}],"subject":[],"published":{"date-parts":[[2022,9,21]]}}}